POSTJUNCTIONAL INHIBITORY EFFECT OF THE NK(2) RECEPTOR ANTAGONIST, SR 48968, ON SENSORY NANC BRONCHOCONSTRICTION IN THE GUINEA-PIG

被引:34
|
作者
LOU, YP [1 ]
LEE, LY [1 ]
SATOH, H [1 ]
LUNDBERG, JM [1 ]
机构
[1] KAROLINSKA INST,DEPT PHARMACOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN
关键词
BRONCHOCONSTRICTION; CAPSAICIN; CALCITONIN GENE-RELATED PEPTIDE (CGRP); NEUROKININ A; NK(2) RECEPTOR ANTAGONIST; SUBSTANCE-P; SR; 48968; VAGAL STIMULATION;
D O I
10.1111/j.1476-5381.1993.tb13640.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of a selective NK2 receptor antagonist, SR 48968, on non-adrenergic non-cholinergic (NANC) bronchoconstriction in the guinea-pig were investigated in both in vitro and in vivo studies. 2 In isolated bronchus, the electrical field stimulation (EFS, 1 Hz for 1 min)-induced NANC bronchoconstriction was inhibited by 83% after preincubation with SR 48968 (10(-7) m) for 1 h. The selective NK1 receptor antagonist, CP 96,345 (10(-6) M), together with SR 48968 completely abolished the remaining EFS-evoked NANC bronchial contraction. ST 48968 (10(-7) M) totally blocked the bronchial contraction caused by neurokinin A (NKA), but reduced only slightly the bronchoconstriction caused by high concentrations of substance P (SP) and did not influence the response to acetylcholine (ACh). 3 In the guinea-pig isolated perfused lung, SR 48968 (5 x 10(-7) m) perfusion for 30 min markedly reduced, by 95% and 68% respectively, the increase in lung resistance (R(L)) and the decrease in dynamic compliance (C(Dyn)) evoked by vagal stimulation (I Hz for 1 min). Capsaicin (10(-8) m)-evoked bronchoconstriction was also significantly inhibited by SR 48968 (5 x 10(-7) m). However, the same concentration of SR 48968 did not affect the release of neuropeptide calcitonin gene-related peptide (CGRP)-like immunoreactivity (LI) evoked by either vagal stimulation or capsaicin in the isolated perfused lung, suggesting no prejunctional action. SR 48968 (5 x 10(-7) m) caused a parallel shift of the concentration-response curve to the right by a factor of 10 for the bronchoconstriction evoked by NKA (10(-9)-3 x 10(-7) M) in the isolated lung, while it abolished the contraction induced by the selective NK2 receptor agonist, Nle10 NKA(4-10) (10(-9)-3 x 10(-7) M). 4 In in vivo studies, ST 48968 (0.3 mg kg-1, i.v.) also greatly inhibited the increase in insufflation pressure evoked by either capsaicin (10 mug kg-1, i.v.) or NKA (1 mug kg-1, i.v.), without any measurable effect on the accompanying hypotensive responses. 5 The results suggest: (i) ST 48968 is a selective and potent NK2 postjunctional receptor antagonist both in vitro and in vivo in the guinea-pig, and (ii) the NANC bronchoconstriction evoked by sensory nerve activation either by antidromic nerve stimulation or by capsaicin is mediated mainly via NK2 receptors and only to a minor extent via NK1 receptors.
引用
收藏
页码:765 / 773
页数:9
相关论文
共 50 条
  • [1] POST JUNCTIONAL INHIBITORY EFFECT OF THE NK2 RECEPTOR ANTAGONIST SR-48968 ON THE SENSORY NANC BRONCHOCONSTRICTION IN GUINEA-PIGS
    LOU, YP
    LEE, LY
    SATOH, H
    LUNDBERG, JM
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A707 - A707
  • [2] THE NONPEPTIDE NK-2 ANTAGONIST SR 48968 IS ALSO A NK-3 ANTAGONIST IN THE GUINEA-PIG BUT NOT IN THE RAT
    PETITET, F
    BEAUJOUAN, JC
    SAFFROY, M
    TORRENS, Y
    GLOWINSKI, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 191 (01) : 180 - 187
  • [3] INHIBITORY EFFECTS OF CAPSAZEPINE AND THE NK2 ANTAGONIST SR-48968 ON BRONCHOCONSTRICTION EVOKED BY SENSORY NERVE-STIMULATION IN GUINEA-PIGS
    SATOH, H
    LOU, YP
    LEE, LY
    LUNDBERG, JM
    ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 146 (04): : 535 - 536
  • [4] The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics
    Van Schoor, J
    Joos, GF
    Chasson, BL
    Brouard, RJ
    Pauwels, RA
    EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (01) : 17 - 23
  • [5] ANTITUSSIVE EFFECT OF SR 48968, A NONPEPTIDE TACHYKININ NK(2) RECEPTOR ANTAGONIST
    ADVENIER, C
    GIRARD, V
    NALINE, E
    VILAIN, P
    EMONDSALT, X
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (01) : 169 - 171
  • [6] SR 48968, A NEUROKININ A (NK2) RECEPTOR ANTAGONIST
    EMONDSALT, X
    ADVENIER, C
    LEFUR, G
    BRELIERE, JC
    REGULATORY PEPTIDES, 1992, : S4 - S4
  • [7] SR-48968, A NEUROKININ-A (NK2) RECEPTOR ANTAGONIST
    EMONDSALT, X
    ADVENIER, C
    CROCI, T
    MANARA, L
    NELIAT, G
    PONCELET, M
    PROIETTO, V
    SANTUCCI, V
    SOUBRIE, P
    VANBROECK, D
    VILAIN, P
    LEFUR, G
    BRELIERE, JC
    REGULATORY PEPTIDES, 1993, 46 (1-2) : 31 - 36
  • [8] SR-48968, A NOVEL NONPEPTIDE TACHYKININ NK-2-RECEPTOR ANTAGONIST, SELECTIVELY INHIBITS THE NONCHOLINERGICALLY MEDIATED NEUROGENIC CONTRACTION OF GUINEA-PIG ISOLATED BRONCHIAL MUSCLE
    KAMIKAWA, Y
    SHIMO, Y
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (12) : 1037 - 1041
  • [9] Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea-pig and cat
    Bolser, DC
    DeGennaro, FC
    OReilly, S
    McLeod, RL
    Hey, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) : 165 - 170
  • [10] EFFECT OF THE HISTAMINE-H1 ANTAGONIST ASTEMIZOLE ON BRONCHOCONSTRICTION IN THE GUINEA-PIG
    SCHUURKES, JAJ
    VANNUETEN, JM
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1983, 265 (01): : 164 - 166